MVP, the major vault protein, was shown to be linked to multidrug resistance in a series of cancers [57] including PCa [58], and was recently proposed as a biomarker for lethal outcomes in PCa by Ramberg and colleagues [59]. The gene discussed is MVP; the disease is cancer.